SlideShare a Scribd company logo
Chronic Interstitial
Pneumonia
Dr. Karima Al-Salihi
•It is the chronic inflammation of the
interstitial tissues.
It is caused by:
(1) Viral infection.
(2) Infestation with lung worm.
(3) Secondary to lobar and lobular
pneumonia when the exudate becomes
organized.
(4) Secondary to some specific disease
e.g. Tuberculosis, Contagious bovine
pleuropneumonia in cattle.
Clinical findings:
(1) Severe mixed dyspnoea.
(2) Easily induced cough.
(3) Slight rise o f temperature (it is very high in
infectious diseases).
(4) On percussion, dullness is heard on the anterior
and posterior borders of the lungs.
(5) On auscultation, week or absence of vesicular
sound but rales may be heard.
(6) Consolidation and fibrosis of the lung will cause
reduction in the respiratory surface, the lung will
loose some of its power of expansion as well as
some of its elasticity and this lead to death from
asphyxia.
Pneumonia in pet animals
Acute and chronic inflammatory
changes of the lungs and bronchi
characterized by respiratory
disturbances and complicated by
systemic effects of toxins
absorbed from the involved area.
Causes:
(1) Primary viral involvement of the respiratory
tract followed -by secondary bacterial
invasion: e.g. Feline respiratory complex,
Canine distemper, Infectious tracheobronchitis
and Canine and Feline herpes virus.
(2) Classical pneumonia is due to bacterial
invasion.
(3) Parasitic invasion o f the bronchi as by
filaroides Aelurostronglus.
(4) Protozoan involvement, usually caused by
Toxoplasma.
(5) Mycotic bronchopneumonia may
result from Aspergillus or Histoplasma.
(6) Injury to the bronchial mucosa and
the inhalation or aspiration o f irritant
materials may cause pneumonia
directly and predispose the tissues to
secondary bacterial invasion.
NB: Any interference with immune
protective mechanisms may
predispose to pneumonia.
Clinical findings:
(1)Drowsiness (lethargy).
(2) Anorexia.
(3) Deep cough o f low amplitude.
(4) Nasal ocular discharge.
(5) Progressive dyspnea.
(6) Increased body temperature.
(7) Blowing of the lips and cyanosis.
(8) Auscultation of the thorax usually reveals
consolidation.
(9) Complication such as pleuritis may occur.
Course o f the
Pneumonia:
(1) Lobar pneumonia: 7-10
days in horse, 3 weeks in
cattle
(2) Bronchopneumonia:
3-4 weeks in both.
Death may occurs in pneumonia from:
(1)Anoxia and respiratory failure.
(2)Heart failure
(3) Pleurisy.
(4) Pericarditis.
(5) Gangrenous pneumonia.
Clinical pathology:
(1) Respiratory secretion, exudates, nasal swabs,
tracheobronchial aspirates and bronchoalveolar lavage
samples can be submitted for isolation of viruses, bacteria,
fungi, cytological examination and determination of
antimicrobial sensitivity.
(2) Thoracentesis: when pleural effusion is suspected, to
obtain pleural fluid for analysis.
(3) Hematology: hematological
examination can be done if the infection is
bacterial or viral in nature and its severity.
1- PCV elevated in severely toxemic
animals which aren’t drinking water.
2- Severe bacterial bronchopneumonia and
pleuritis is charactrized by marked increase
in leukocytic count (leukocytosis).
3- Serum fibrinogen concentrations are
markedly elevated in horses with
pleuropneumonia and pleuritis.
(4) Fecal samples: for the detection of the
larvae when lungworm pneumonia is
suspected.
(5) Medical imaging: thoracic radiography and
ultrasonography.
(6) Respiratory function tests e.g. blood
gases and acid base balance tests.
(7) Necropsy: Necropsy o f selected early
cases will often assist in making a diagnosis
in outbreaks o f respiratory disease.
Diagnosis o f pneumonia
depends on:
(1) History.
(2) Clinical symptoms (Polypnea
in the early stages, dyspnea in
late stage, abnormal lung
sounds, cough, fever and
toxemia in bacterial pneumonia).
(3) Clinical pathology.
Differential diagnosis:
(1) Polypnea and dyspnea may result from
involvement of other body systems disturbances e.g.
1- Congestive heart failure.
2- Poisoning by histotoxic agents e.g. hydrocyanic acid.
3- Hyperthermia.
4- Acidosis.
The previous diseases are accompanied by respiratory
embarrassments but not by abnormal respiratory sounds,
which present in pulmonary involvement.
(2) Pleuritis is characterized by:
1) Shallow, abdominal type of respiration.
2) Friction sounds in the early stage and muffling lung
sounds. Fluid line detected by auscultation and
percussion in late stage.
•
(3) Pneumothorax is characterized by:
1) Inspiratory dyspnea.
2) An absence of vesicular sounds.
3) Bronchial sounds are audible over the base of the lung.
4) Hyperresonant sound on percussion.
(4) Contagious Bovine Pleuro-
pneumonia:
!It is a highly infectious septicemic
disease caused by mycoplasma
mycoides characterized by localization
in the lungs and pleura resulting to
acute lobar pneumonia and pleurisy.
!It occurs commonly in cattle and it is
characterized by high morbidity and
mortality rates.
•Treatment of
pneumonia
(1) Avoid overcrowding and put the animal in worm dry
place free from air current and apply chest rug.
(2) Correct anaemia if present.
(3) Oxygen therapy if cyanosis is severe.
(4) Feed animal with easily digestible and palatable food
(green laxature food for ruminants, bran mash for
equines).
(5) Injection of vitamin C and A to increase body immunity.
(6) Expectorant e.g. Bisolvone (mucolytic and expectorant)
or  trisolven (mucolytic, expectorant and bronchodilator) 1
ml/50 KgBW, IM, daily till recovery.
(7) Bronchodilators: to improves ventilation and tends to
correct oxygen exchange e.g. Aminophylline and
theophylline I.V. injection.
(8) Glucose 5-10%, 500 ml and saline solution 0.9%, 500
ml (or more) daily to control dehydration.
(9) Diuretics: e.g. pot. acetate and pot. citrate 15 gm from
each are added to the drinking water o f the animal every
day.
(10) Antimicrobial therapy: one o f the
following:
1) Oxytetracycline (5 mg/kgBW IM for 5-7
days).
2) Long acting tetracyclines at 10 mg/kg.
3) SC enrofloxacin (5 mg/kg)
4) Procaine penicillin 4000 IU/kg daily IM for
5-7 days.
5) Sulfonamides 200 mg/Kg for 5-7 days.
6) Combination of oxytetracycline and
sulfonamides.
7) Combination of tetracycline and penicillin.
(11) Anti-inflammatory therapy : one of the
following:
1) Corticosteroids and antihistamines, such as
dexamethasone 5-25 mg given I/M or I/V.
2) Non Steroidal anti-inflammatory drugs
(NSAIDs) such as acetyl salycilic acid (asprin)
(100 mg/kg every m hours) or flunixen
meglumine (2 mg/kg) either a single dose or
divided into two doses at 12 hour intervals.
NB: Care should be taken from renal toxicity,
so dehydrated animals should be rehydrated
before administration of these drugs.
NB: Avoid over dose or use them for prolonged
period because they may result in abomasal
ulceration.
(12) Heart tonic: one of the following:
1) Cardiazole 1-2 gm for horse according to
size.
2) Pulve digitalis. 1-4 gm for large animal. 1 /
2-4 gm for small animal. This dose must be
divided in 3 parts and given 3 times in three
days.
3) Repherin or pholiderin or adcopherine (IM),
5-10 c.c for large animal, 1 / 2-1 c.c. for small
animal.
* No treatment for interstitial pneumonia and the
diseased cattle should be slaughtered.
•
*MB: There is no specific treatment for the viral
pneumonias while mycoplasma spp. are sensitive to
antibiotics in vitro.
So, the pneumonias caused by them don’t respond to
treatment. This may be due to the intercellular location o
f the mycoplasma making them inaccessible to the
drugs.
Because, viral and mycoplasma pneumonias are
commonly complicated by secondary bacterial
infections, it is common practice to treat them with
antibiotics until recovery.
* Corticosteroids as anti-inflammatory effect in the
treatment o f acute pneumonia.
Prevention and control:
(1) Vaccination o f healthy dams.
(2) Good colostrum management, to give
adequate passive transfer.
(3) Disinfection o f calves’ navels to limit
pathogen exposure by over crowding and
direct contact.
(4) Provide a good-quality air and protects
the calf from bad environment.
(5) Avoid exposure of newborn to cold or
current air.
(6) Calves should be fed proper nutrition
for protein, energy, minerals and vitamins.
(7) Vaccination programs in dairy calves
should be start at 1-2 months o f age.
 (8) Avoid over crowding and long
transportation in bad weather.
(9) Mass medication can be used to control
outbreaks of pneumonia in flocks.
Sulfonamides are administered in the
drinking water or orally at 200 mg/kg on the
first day and 66 mg/kg each subsequent day
of treatment.

More Related Content

What's hot

Pneumonia
PneumoniaPneumonia
Pneumonia000 07
 
5 pneumonia
5 pneumonia5 pneumonia
5 pneumonia
Claudiu Cucu
 
classification of pnemonia
classification of pnemoniaclassification of pnemonia
classification of pnemonia
Dr Harikrishna Harindran
 
Bordetella pertusis
Bordetella pertusisBordetella pertusis
Bordetella pertusis
hina amir
 
SEVER Viral pneumonia last
SEVER Viral pneumonia lastSEVER Viral pneumonia last
SEVER Viral pneumonia last
Dr.Tarek Sabry
 
Acute respiratory diseases in children
Acute respiratory diseases in childrenAcute respiratory diseases in children
Acute respiratory diseases in children
Ganapathy Tamilselvan
 
Plague disease
Plague diseasePlague disease
Plague disease
Ajay Dominic
 
Diagnosis of Upper and Lower Respiratory Tract Infections
Diagnosis of Upper and Lower Respiratory Tract InfectionsDiagnosis of Upper and Lower Respiratory Tract Infections
Diagnosis of Upper and Lower Respiratory Tract InfectionsOluwatosin Ogunwola
 
Unit II
Unit IIUnit II
Unit II
Alvin Angeles
 
Pneumonia
PneumoniaPneumonia
Pneumonia
Akram bhuiyan
 
Copy of pneumonia
Copy of pneumoniaCopy of pneumonia
Copy of pneumoniakcmct20
 
Upper respiratory tract infections
Upper respiratory tract infectionsUpper respiratory tract infections
Upper respiratory tract infections
Kaveh Haratian
 
Upper respiratory infections
Upper respiratory infectionsUpper respiratory infections
Upper respiratory infections
Chris Kokkola
 
Pneumonia Micro2
Pneumonia Micro2Pneumonia Micro2
Pneumonia Micro2
brian kieth gonzales
 
Clinical features investigation of pulmonary tb
Clinical features investigation of pulmonary tbClinical features investigation of pulmonary tb
Clinical features investigation of pulmonary tb
roshanjha8888
 
Diptheria
DiptheriaDiptheria

What's hot (20)

Pneumonia
PneumoniaPneumonia
Pneumonia
 
5 pneumonia
5 pneumonia5 pneumonia
5 pneumonia
 
classification of pnemonia
classification of pnemoniaclassification of pnemonia
classification of pnemonia
 
Bordetella pertusis
Bordetella pertusisBordetella pertusis
Bordetella pertusis
 
SEVER Viral pneumonia last
SEVER Viral pneumonia lastSEVER Viral pneumonia last
SEVER Viral pneumonia last
 
Acute respiratory diseases in children
Acute respiratory diseases in childrenAcute respiratory diseases in children
Acute respiratory diseases in children
 
Plague disease
Plague diseasePlague disease
Plague disease
 
Lungworm infection
Lungworm infectionLungworm infection
Lungworm infection
 
Diagnosis of Upper and Lower Respiratory Tract Infections
Diagnosis of Upper and Lower Respiratory Tract InfectionsDiagnosis of Upper and Lower Respiratory Tract Infections
Diagnosis of Upper and Lower Respiratory Tract Infections
 
Unit II
Unit IIUnit II
Unit II
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Copy of pneumonia
Copy of pneumoniaCopy of pneumonia
Copy of pneumonia
 
Upper respiratory tract infections
Upper respiratory tract infectionsUpper respiratory tract infections
Upper respiratory tract infections
 
Upper respiratory infections
Upper respiratory infectionsUpper respiratory infections
Upper respiratory infections
 
Pneumonia Micro2
Pneumonia Micro2Pneumonia Micro2
Pneumonia Micro2
 
Clinical features investigation of pulmonary tb
Clinical features investigation of pulmonary tbClinical features investigation of pulmonary tb
Clinical features investigation of pulmonary tb
 
Chapter24
Chapter24Chapter24
Chapter24
 
Diptheria
DiptheriaDiptheria
Diptheria
 
RTIs
RTIsRTIs
RTIs
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 

Similar to 6 chronic interstitial pneumonia

7 aspiration pneumonia
7 aspiration pneumonia 7 aspiration pneumonia
7 aspiration pneumonia
karima Akool AlSalihi
 
Pulmonology
PulmonologyPulmonology
Pulmonology
Mr. Dipti sorte
 
4 diseases o f the bronchi
4 diseases o f the bronchi 4 diseases o f the bronchi
4 diseases o f the bronchi
karima Akool AlSalihi
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
SAMOEINESH
 
Gwen med surg pneumonia final
Gwen med surg pneumonia finalGwen med surg pneumonia final
Gwen med surg pneumonia final
Gwenneth Zoelie Nongkhlaw
 
Ovine progressive pneumonia
Ovine progressive pneumoniaOvine progressive pneumonia
Ovine progressive pneumonia
Dr-Mohamed Ghanem
 
Pulmonary adenomatosis by prof mohamed ghanem
Pulmonary adenomatosis by prof mohamed ghanemPulmonary adenomatosis by prof mohamed ghanem
Pulmonary adenomatosis by prof mohamed ghanem
Dr-Mohamed Ghanem
 
5 diseases of the lung pneumonia
5 diseases of the lung   pneumonia 5 diseases of the lung   pneumonia
5 diseases of the lung pneumonia
karima Akool AlSalihi
 
Infectious Coryza_The Disease
Infectious Coryza_The DiseaseInfectious Coryza_The Disease
Infectious Coryza_The Disease
Ossama Motawae
 
Fowel Cholera
Fowel CholeraFowel Cholera
Fowel Cholera
Ossama Motawae
 
Respiratory disorders.pptx
Respiratory disorders.pptxRespiratory disorders.pptx
Respiratory disorders.pptx
RuchiPal10
 
5 diseases of the lung pneumonia
5 diseases of the lung   pneumonia 5 diseases of the lung   pneumonia
5 diseases of the lung pneumonia
karima Akool AlSalihi
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
NEENUVARGHESE8
 
Differential diagnosis of cough in pediatric patients
Differential diagnosis of cough in pediatric patientsDifferential diagnosis of cough in pediatric patients
Differential diagnosis of cough in pediatric patients
6nhstkf7f2
 
Infiltrative eosinophilias of lung
Infiltrative eosinophilias of lungInfiltrative eosinophilias of lung
Infiltrative eosinophilias of lung
Dinoosh De Livera
 
Pneumonia
PneumoniaPneumonia
Pneumonia
asadullah ansari
 
Bronchiectases
BronchiectasesBronchiectases
Bronchiectases
GAMANDEEP
 
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluationChildhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
Lokanath Reddy Mummadi
 
Pneumonia in ruminants.pptx
Pneumonia in ruminants.pptxPneumonia in ruminants.pptx

Similar to 6 chronic interstitial pneumonia (20)

7 aspiration pneumonia
7 aspiration pneumonia 7 aspiration pneumonia
7 aspiration pneumonia
 
Pulmonology
PulmonologyPulmonology
Pulmonology
 
4 diseases o f the bronchi
4 diseases o f the bronchi 4 diseases o f the bronchi
4 diseases o f the bronchi
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
 
Gwen med surg pneumonia final
Gwen med surg pneumonia finalGwen med surg pneumonia final
Gwen med surg pneumonia final
 
Ovine progressive pneumonia
Ovine progressive pneumoniaOvine progressive pneumonia
Ovine progressive pneumonia
 
Pulmonary adenomatosis by prof mohamed ghanem
Pulmonary adenomatosis by prof mohamed ghanemPulmonary adenomatosis by prof mohamed ghanem
Pulmonary adenomatosis by prof mohamed ghanem
 
5 diseases of the lung pneumonia
5 diseases of the lung   pneumonia 5 diseases of the lung   pneumonia
5 diseases of the lung pneumonia
 
Infectious Coryza_The Disease
Infectious Coryza_The DiseaseInfectious Coryza_The Disease
Infectious Coryza_The Disease
 
Fowel Cholera
Fowel CholeraFowel Cholera
Fowel Cholera
 
Respiratory disorders.pptx
Respiratory disorders.pptxRespiratory disorders.pptx
Respiratory disorders.pptx
 
5 diseases of the lung pneumonia
5 diseases of the lung   pneumonia 5 diseases of the lung   pneumonia
5 diseases of the lung pneumonia
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
 
Differential diagnosis of cough in pediatric patients
Differential diagnosis of cough in pediatric patientsDifferential diagnosis of cough in pediatric patients
Differential diagnosis of cough in pediatric patients
 
Infiltrative eosinophilias of lung
Infiltrative eosinophilias of lungInfiltrative eosinophilias of lung
Infiltrative eosinophilias of lung
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Bronchiectases
BronchiectasesBronchiectases
Bronchiectases
 
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluationChildhood asthma - etiopathogenesis,clinical manifestations and evaluation
Childhood asthma - etiopathogenesis,clinical manifestations and evaluation
 
Bacterial diseases
Bacterial diseasesBacterial diseases
Bacterial diseases
 
Pneumonia in ruminants.pptx
Pneumonia in ruminants.pptxPneumonia in ruminants.pptx
Pneumonia in ruminants.pptx
 

More from karima Akool AlSalihi

8 dermatology (skin diseases)
8 dermatology(skin diseases)8 dermatology(skin diseases)
8 dermatology (skin diseases)
karima Akool AlSalihi
 
16 copper deficiency and associated diseases part 2
16 copper deficiency andassociated diseases part 216 copper deficiency andassociated diseases part 2
16 copper deficiency and associated diseases part 2
karima Akool AlSalihi
 
19 vitamin a deficiency: deficiency of fat soluble vitamins
19 vitamin a deficiency: deficiency of fat soluble vitamins 19 vitamin a deficiency: deficiency of fat soluble vitamins
19 vitamin a deficiency: deficiency of fat soluble vitamins
karima Akool AlSalihi
 
18 selenium and:or vitamin e deficiency
18 selenium and:or vitamin e deficiency 18 selenium and:or vitamin e deficiency
18 selenium and:or vitamin e deficiency
karima Akool AlSalihi
 
17 zinc,cobalt, iodine deficiencies
17 zinc,cobalt, iodine deficiencies17 zinc,cobalt, iodine deficiencies
17 zinc,cobalt, iodine deficiencies
karima Akool AlSalihi
 
15 copper deficiency part 1
15 copper deficiency part 115 copper deficiency part 1
15 copper deficiency part 1
karima Akool AlSalihi
 
14 deficiency of trace elements
14 deficiency of trace elements 14 deficiency of trace elements
14 deficiency of trace elements
karima Akool AlSalihi
 
13 osteomalacia
13 osteomalacia13 osteomalacia
13 osteomalacia
karima Akool AlSalihi
 
12 introduction to nutritional deficincies
12 introduction to nutritional deficincies 12 introduction to nutritional deficincies
12 introduction to nutritional deficincies
karima Akool AlSalihi
 
13 clinical examination of skin and appendages in animals
13 clinical examination of skin and appendages in animals13 clinical examination of skin and appendages in animals
13 clinical examination of skin and appendages in animals
karima Akool AlSalihi
 
12 examination of the udder
12 examination of the udder 12 examination of the udder
12 examination of the udder
karima Akool AlSalihi
 
10 clinical examination lymph nodes
10 clinical examination lymph nodes  10 clinical examination lymph nodes
10 clinical examination lymph nodes
karima Akool AlSalihi
 
12 examination of the urogenital system
12 examination of the urogenital system12 examination of the urogenital system
12 examination of the urogenital system
karima Akool AlSalihi
 
29 june 2020 clinical case
29 june 2020 clinical case 29 june 2020 clinical case
29 june 2020 clinical case
karima Akool AlSalihi
 
Bovine theileriosis
Bovine theileriosisBovine theileriosis
Bovine theileriosis
karima Akool AlSalihi
 
28 june 2020 reticuloperitonitis
28 june 2020 reticuloperitonitis28 june 2020 reticuloperitonitis
28 june 2020 reticuloperitonitis
karima Akool AlSalihi
 
27 june 2020 , bovine clinical case
27 june 2020 , bovine clinical case27 june 2020 , bovine clinical case
27 june 2020 , bovine clinical case
karima Akool AlSalihi
 
9 examination of digestive system
9 examination of digestive system 9 examination of digestive system
9 examination of digestive system
karima Akool AlSalihi
 
8 clinical examination of cardiovascular system in animals
8 clinical examination of cardiovascular system in animals8 clinical examination of cardiovascular system in animals
8 clinical examination of cardiovascular system in animals
karima Akool AlSalihi
 
11 diseases of musculoskeletal system ) part 2)
11 diseases of musculoskeletal system ) part 2)  11 diseases of musculoskeletal system ) part 2)
11 diseases of musculoskeletal system ) part 2)
karima Akool AlSalihi
 

More from karima Akool AlSalihi (20)

8 dermatology (skin diseases)
8 dermatology(skin diseases)8 dermatology(skin diseases)
8 dermatology (skin diseases)
 
16 copper deficiency and associated diseases part 2
16 copper deficiency andassociated diseases part 216 copper deficiency andassociated diseases part 2
16 copper deficiency and associated diseases part 2
 
19 vitamin a deficiency: deficiency of fat soluble vitamins
19 vitamin a deficiency: deficiency of fat soluble vitamins 19 vitamin a deficiency: deficiency of fat soluble vitamins
19 vitamin a deficiency: deficiency of fat soluble vitamins
 
18 selenium and:or vitamin e deficiency
18 selenium and:or vitamin e deficiency 18 selenium and:or vitamin e deficiency
18 selenium and:or vitamin e deficiency
 
17 zinc,cobalt, iodine deficiencies
17 zinc,cobalt, iodine deficiencies17 zinc,cobalt, iodine deficiencies
17 zinc,cobalt, iodine deficiencies
 
15 copper deficiency part 1
15 copper deficiency part 115 copper deficiency part 1
15 copper deficiency part 1
 
14 deficiency of trace elements
14 deficiency of trace elements 14 deficiency of trace elements
14 deficiency of trace elements
 
13 osteomalacia
13 osteomalacia13 osteomalacia
13 osteomalacia
 
12 introduction to nutritional deficincies
12 introduction to nutritional deficincies 12 introduction to nutritional deficincies
12 introduction to nutritional deficincies
 
13 clinical examination of skin and appendages in animals
13 clinical examination of skin and appendages in animals13 clinical examination of skin and appendages in animals
13 clinical examination of skin and appendages in animals
 
12 examination of the udder
12 examination of the udder 12 examination of the udder
12 examination of the udder
 
10 clinical examination lymph nodes
10 clinical examination lymph nodes  10 clinical examination lymph nodes
10 clinical examination lymph nodes
 
12 examination of the urogenital system
12 examination of the urogenital system12 examination of the urogenital system
12 examination of the urogenital system
 
29 june 2020 clinical case
29 june 2020 clinical case 29 june 2020 clinical case
29 june 2020 clinical case
 
Bovine theileriosis
Bovine theileriosisBovine theileriosis
Bovine theileriosis
 
28 june 2020 reticuloperitonitis
28 june 2020 reticuloperitonitis28 june 2020 reticuloperitonitis
28 june 2020 reticuloperitonitis
 
27 june 2020 , bovine clinical case
27 june 2020 , bovine clinical case27 june 2020 , bovine clinical case
27 june 2020 , bovine clinical case
 
9 examination of digestive system
9 examination of digestive system 9 examination of digestive system
9 examination of digestive system
 
8 clinical examination of cardiovascular system in animals
8 clinical examination of cardiovascular system in animals8 clinical examination of cardiovascular system in animals
8 clinical examination of cardiovascular system in animals
 
11 diseases of musculoskeletal system ) part 2)
11 diseases of musculoskeletal system ) part 2)  11 diseases of musculoskeletal system ) part 2)
11 diseases of musculoskeletal system ) part 2)
 

Recently uploaded

Anemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditionsAnemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditions
muralinath2
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
AADYARAJPANDEY1
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
Michel Dumontier
 
Predicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdfPredicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdf
binhminhvu04
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
Sérgio Sacani
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
justice-and-fairness-ethics with example
justice-and-fairness-ethics with examplejustice-and-fairness-ethics with example
justice-and-fairness-ethics with example
azzyixes
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
YOGESH DOGRA
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
IqrimaNabilatulhusni
 

Recently uploaded (20)

Anemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditionsAnemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditions
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
 
Predicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdfPredicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdf
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
justice-and-fairness-ethics with example
justice-and-fairness-ethics with examplejustice-and-fairness-ethics with example
justice-and-fairness-ethics with example
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
 

6 chronic interstitial pneumonia

  • 2. •It is the chronic inflammation of the interstitial tissues. It is caused by: (1) Viral infection. (2) Infestation with lung worm. (3) Secondary to lobar and lobular pneumonia when the exudate becomes organized. (4) Secondary to some specific disease e.g. Tuberculosis, Contagious bovine pleuropneumonia in cattle.
  • 3.
  • 4. Clinical findings: (1) Severe mixed dyspnoea. (2) Easily induced cough. (3) Slight rise o f temperature (it is very high in infectious diseases). (4) On percussion, dullness is heard on the anterior and posterior borders of the lungs. (5) On auscultation, week or absence of vesicular sound but rales may be heard. (6) Consolidation and fibrosis of the lung will cause reduction in the respiratory surface, the lung will loose some of its power of expansion as well as some of its elasticity and this lead to death from asphyxia.
  • 5. Pneumonia in pet animals Acute and chronic inflammatory changes of the lungs and bronchi characterized by respiratory disturbances and complicated by systemic effects of toxins absorbed from the involved area.
  • 6.
  • 7. Causes: (1) Primary viral involvement of the respiratory tract followed -by secondary bacterial invasion: e.g. Feline respiratory complex, Canine distemper, Infectious tracheobronchitis and Canine and Feline herpes virus. (2) Classical pneumonia is due to bacterial invasion. (3) Parasitic invasion o f the bronchi as by filaroides Aelurostronglus. (4) Protozoan involvement, usually caused by Toxoplasma.
  • 8. (5) Mycotic bronchopneumonia may result from Aspergillus or Histoplasma. (6) Injury to the bronchial mucosa and the inhalation or aspiration o f irritant materials may cause pneumonia directly and predispose the tissues to secondary bacterial invasion. NB: Any interference with immune protective mechanisms may predispose to pneumonia.
  • 9.
  • 10. Clinical findings: (1)Drowsiness (lethargy). (2) Anorexia. (3) Deep cough o f low amplitude. (4) Nasal ocular discharge. (5) Progressive dyspnea. (6) Increased body temperature. (7) Blowing of the lips and cyanosis. (8) Auscultation of the thorax usually reveals consolidation. (9) Complication such as pleuritis may occur.
  • 11. Course o f the Pneumonia: (1) Lobar pneumonia: 7-10 days in horse, 3 weeks in cattle (2) Bronchopneumonia: 3-4 weeks in both.
  • 12. Death may occurs in pneumonia from: (1)Anoxia and respiratory failure. (2)Heart failure (3) Pleurisy. (4) Pericarditis. (5) Gangrenous pneumonia. Clinical pathology: (1) Respiratory secretion, exudates, nasal swabs, tracheobronchial aspirates and bronchoalveolar lavage samples can be submitted for isolation of viruses, bacteria, fungi, cytological examination and determination of antimicrobial sensitivity. (2) Thoracentesis: when pleural effusion is suspected, to obtain pleural fluid for analysis.
  • 13. (3) Hematology: hematological examination can be done if the infection is bacterial or viral in nature and its severity. 1- PCV elevated in severely toxemic animals which aren’t drinking water. 2- Severe bacterial bronchopneumonia and pleuritis is charactrized by marked increase in leukocytic count (leukocytosis). 3- Serum fibrinogen concentrations are markedly elevated in horses with pleuropneumonia and pleuritis.
  • 14. (4) Fecal samples: for the detection of the larvae when lungworm pneumonia is suspected. (5) Medical imaging: thoracic radiography and ultrasonography. (6) Respiratory function tests e.g. blood gases and acid base balance tests. (7) Necropsy: Necropsy o f selected early cases will often assist in making a diagnosis in outbreaks o f respiratory disease.
  • 15. Diagnosis o f pneumonia depends on: (1) History. (2) Clinical symptoms (Polypnea in the early stages, dyspnea in late stage, abnormal lung sounds, cough, fever and toxemia in bacterial pneumonia). (3) Clinical pathology.
  • 16. Differential diagnosis: (1) Polypnea and dyspnea may result from involvement of other body systems disturbances e.g. 1- Congestive heart failure. 2- Poisoning by histotoxic agents e.g. hydrocyanic acid. 3- Hyperthermia. 4- Acidosis. The previous diseases are accompanied by respiratory embarrassments but not by abnormal respiratory sounds, which present in pulmonary involvement.
  • 17. (2) Pleuritis is characterized by: 1) Shallow, abdominal type of respiration. 2) Friction sounds in the early stage and muffling lung sounds. Fluid line detected by auscultation and percussion in late stage. • (3) Pneumothorax is characterized by: 1) Inspiratory dyspnea. 2) An absence of vesicular sounds. 3) Bronchial sounds are audible over the base of the lung. 4) Hyperresonant sound on percussion.
  • 18. (4) Contagious Bovine Pleuro- pneumonia: !It is a highly infectious septicemic disease caused by mycoplasma mycoides characterized by localization in the lungs and pleura resulting to acute lobar pneumonia and pleurisy. !It occurs commonly in cattle and it is characterized by high morbidity and mortality rates.
  • 19.
  • 20. •Treatment of pneumonia (1) Avoid overcrowding and put the animal in worm dry place free from air current and apply chest rug. (2) Correct anaemia if present. (3) Oxygen therapy if cyanosis is severe. (4) Feed animal with easily digestible and palatable food (green laxature food for ruminants, bran mash for equines). (5) Injection of vitamin C and A to increase body immunity.
  • 21. (6) Expectorant e.g. Bisolvone (mucolytic and expectorant) or  trisolven (mucolytic, expectorant and bronchodilator) 1 ml/50 KgBW, IM, daily till recovery. (7) Bronchodilators: to improves ventilation and tends to correct oxygen exchange e.g. Aminophylline and theophylline I.V. injection. (8) Glucose 5-10%, 500 ml and saline solution 0.9%, 500 ml (or more) daily to control dehydration. (9) Diuretics: e.g. pot. acetate and pot. citrate 15 gm from each are added to the drinking water o f the animal every day.
  • 22. (10) Antimicrobial therapy: one o f the following: 1) Oxytetracycline (5 mg/kgBW IM for 5-7 days). 2) Long acting tetracyclines at 10 mg/kg. 3) SC enrofloxacin (5 mg/kg) 4) Procaine penicillin 4000 IU/kg daily IM for 5-7 days. 5) Sulfonamides 200 mg/Kg for 5-7 days. 6) Combination of oxytetracycline and sulfonamides. 7) Combination of tetracycline and penicillin.
  • 23. (11) Anti-inflammatory therapy : one of the following: 1) Corticosteroids and antihistamines, such as dexamethasone 5-25 mg given I/M or I/V. 2) Non Steroidal anti-inflammatory drugs (NSAIDs) such as acetyl salycilic acid (asprin) (100 mg/kg every m hours) or flunixen meglumine (2 mg/kg) either a single dose or divided into two doses at 12 hour intervals. NB: Care should be taken from renal toxicity, so dehydrated animals should be rehydrated before administration of these drugs.
  • 24. NB: Avoid over dose or use them for prolonged period because they may result in abomasal ulceration. (12) Heart tonic: one of the following: 1) Cardiazole 1-2 gm for horse according to size. 2) Pulve digitalis. 1-4 gm for large animal. 1 / 2-4 gm for small animal. This dose must be divided in 3 parts and given 3 times in three days. 3) Repherin or pholiderin or adcopherine (IM), 5-10 c.c for large animal, 1 / 2-1 c.c. for small animal.
  • 25. * No treatment for interstitial pneumonia and the diseased cattle should be slaughtered. • *MB: There is no specific treatment for the viral pneumonias while mycoplasma spp. are sensitive to antibiotics in vitro. So, the pneumonias caused by them don’t respond to treatment. This may be due to the intercellular location o f the mycoplasma making them inaccessible to the drugs. Because, viral and mycoplasma pneumonias are commonly complicated by secondary bacterial infections, it is common practice to treat them with antibiotics until recovery. * Corticosteroids as anti-inflammatory effect in the treatment o f acute pneumonia.
  • 26. Prevention and control: (1) Vaccination o f healthy dams. (2) Good colostrum management, to give adequate passive transfer. (3) Disinfection o f calves’ navels to limit pathogen exposure by over crowding and direct contact. (4) Provide a good-quality air and protects the calf from bad environment. (5) Avoid exposure of newborn to cold or current air.
  • 27. (6) Calves should be fed proper nutrition for protein, energy, minerals and vitamins. (7) Vaccination programs in dairy calves should be start at 1-2 months o f age.  (8) Avoid over crowding and long transportation in bad weather. (9) Mass medication can be used to control outbreaks of pneumonia in flocks. Sulfonamides are administered in the drinking water or orally at 200 mg/kg on the first day and 66 mg/kg each subsequent day of treatment.